Category: Antibody Technologies
Antibody Technologies market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders This study covers the world outlook for therapeutic plasma exchange for neurological disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases
The 2025-2030 World Outlook for Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases This study covers the world outlook for subcutaneous immunoglobulin for primary immunodeficiency diseases across more than 190 countries. For each year reported, estimates are given for the latent deman ... Read More
-
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products This study covers the world outlook for therapeutic monoclonal antibody (mab)-based products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin Technologies
The 2025-2030 World Outlook for Intravenous Immunoglobulin Technologies This study covers the world outlook for intravenous immunoglobulin technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Ion Channel Modulators
The 2025-2030 World Outlook for Ion Channel Modulators This study covers the world outlook for ion channel modulators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Protein Labeling Reagents
The 2025-2030 World Outlook for Protein Labeling Reagents This study covers the world outlook for protein labeling reagents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes This study covers the world outlook for intravenous immunoglobulin for guillain-Barre syndromes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Biosimilar Monoclonal Antibodies (mAb) This study covers the world outlook for biosimilar monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibody Biopharmaceuticals
The 2025-2030 World Outlook for Monoclonal Antibody Biopharmaceuticals This study covers the world outlook for monoclonal antibody biopharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibodies
The 2025-2030 World Outlook for Monoclonal Antibodies This study covers the world outlook for monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Radioimmunoassays
The 2025-2030 World Outlook for Radioimmunoassays This study covers the world outlook for radioimmunoassays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for AntiCD20 Monoclonal Antibodies
The 2025-2030 World Outlook for AntiCD20 Monoclonal Antibodies This study covers the world outlook for AntiCD20 monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Antivenom Serum
The 2025-2030 World Outlook for Antivenom Serum This study covers the world outlook for antivenom serum across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Trastuzumab
The 2025-2030 World Outlook for Trastuzumab This study covers the world outlook for trastuzumab across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Immunoprecipitation
The 2025-2030 World Outlook for Immunoprecipitation This study covers the world outlook for immunoprecipitation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Plasma Therapies
The 2025-2030 World Outlook for Plasma Therapies This study covers the world outlook for plasma therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Immunoglobulin Plasma Therapeutics
The 2025-2030 World Outlook for Immunoglobulin Plasma Therapeutics This study covers the world outlook for immunoglobulin plasma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Therapeutics Proteins
The 2025-2030 World Outlook for Therapeutics Proteins This study covers the world outlook for therapeutics proteins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibodies
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibodies This study covers the world outlook for therapeutic monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Neuroscience Antibodies and Assays Consumables
The 2025-2030 World Outlook for Neuroscience Antibodies and Assays Consumables This study covers the world outlook for neuroscience antibodies and assays consumables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for PEGylated Protein Therapeutics
The 2025-2030 World Outlook for PEGylated Protein Therapeutics This study covers the world outlook for PEGylated protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibodies for Inflammatory Diseases
The 2025-2030 World Outlook for Monoclonal Antibodies for Inflammatory Diseases This study covers the world outlook for monoclonal antibodies for inflammatory diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Cell Surface Marking Antibodies
The 2025-2030 World Outlook for Cell Surface Marking Antibodies This study covers the world outlook for cell surface marking antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Neuroscience Antibodies and Assays
The 2025-2030 World Outlook for Neuroscience Antibodies and Assays This study covers the world outlook for neuroscience antibodies and assays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
Research Assistance
